Detection of respiratory bacterial pathogens causing atypical pneumonia by multiplex Lightmix® RT-PCR by Wagner, Karoline et al.
Zurich Open Repository and
Archive
University of Zurich
Main Library
Strickhofstrasse 39
CH-8057 Zurich
www.zora.uzh.ch
Year: 2018
Detection of respiratory bacterial pathogens causing atypical pneumonia by
multiplex Lightmix® RT-PCR
Wagner, Karoline; Springer, Burkard; Imkamp, Frank; Opota, Onya; Greub, Gilbert; Keller, Peter M
Abstract: Pneumonia is a severe infectious disease. In addition to common viruses and bacterial
pathogens (e.g. Streptococcus pneumoniae), fastidious respiratory pathogens like Chlamydia pneumo-
niae, Mycoplasma pneumoniae and Legionella spp. can cause severe atypical pneumonia. They do not
respond to penicillin derivatives, which may cause failure of antibiotic empirical therapy. The same
applies for infections with B. pertussis and B. parapertussis, the cause of pertussis disease, that may
present atypically and need to be treated with macrolides. Moreover, these fastidious bacteria are diffi-
cult to identify by culture or serology, and therefore often remain undetected. Thus, rapid and accurate
identification of bacterial pathogens causing atypical pneumonia is crucial. We performed a retrospec-
tive method evaluation study to evaluate the diagnostic performance of the new, commercially available
Lightmix® multiplex RT-PCR assay that detects these fastidious bacterial pathogens causing atypical
pneumonia. In this retrospective study, 368 clinical respiratory specimens, obtained from patients suf-
fering from atypical pneumonia that have been tested negative for the presence of common agents of
pneumonia by culture and viral PCR, were investigated. These clinical specimens have been previously
characterized by singleplex RT-PCR assays in our diagnostic laboratory and were used to evaluate the di-
agnostic performance of the respiratory multiplex Lightmix® RT-PCR. The multiplex RT-PCR displayed
a limit of detection between 5 and 10 DNA copies for different in-panel organisms and showed identical
performance characteristics with respect to specificity and sensitivity as in-house singleplex RT-PCRs
for pathogen detection. The Lightmix® multiplex RT-PCR assay represents a low-cost, time-saving and
accurate diagnostic tool with high throughput potential. The time-to-result using an automated DNA
extraction device for respiratory specimens followed by multiplex RT-PCR detection was below 4 h, which
is expected to significantly improve diagnostics for atypical pneumonia-associated bacterial pathogens.
DOI: https://doi.org/10.1016/j.ijmm.2018.01.010
Posted at the Zurich Open Repository and Archive, University of Zurich
ZORA URL: https://doi.org/10.5167/uzh-149194
Published Version
 
 
Originally published at:
Wagner, Karoline; Springer, Burkard; Imkamp, Frank; Opota, Onya; Greub, Gilbert; Keller, Peter M
(2018). Detection of respiratory bacterial pathogens causing atypical pneumonia by multiplex Lightmix®
RT-PCR. International Journal of Medical Microbiology : IJMM, 308(3):317-323.
DOI: https://doi.org/10.1016/j.ijmm.2018.01.010
Contents lists available at ScienceDirect
International Journal of Medical Microbiology
journal homepage: www.elsevier.com/locate/ijmm
Detection of respiratory bacterial pathogens causing atypical pneumonia by
multiplex Lightmix® RT-PCR
Karoline Wagnera, Burkard Springerb, Frank Imkampa, Onya Opotac, Gilbert Greubc,d,
Peter M. Kellera,⁎
a Institute of Medical Microbiology, University of Zurich, Switzerland
b Institute of Medical Microbiology and Hygiene, Austrian Agency for Health and Food Safety, Graz, Austria
c Institute of Microbiology, University of Lausanne and University Hospital Center, Lausanne, Switzerland
d Infectious Diseases Service, University Hospital of Lausanne, Lausanne, Switzerland
A R T I C L E I N F O
Keywords:
Respiratory pathogens
Molecular detection
Multiplex RT-PCR
Atypical pneumonia
High throughput screening
Lightmix® kit
A B S T R A C T
Pneumonia is a severe infectious disease. In addition to common viruses and bacterial pathogens (e.g.
Streptococcus pneumoniae), fastidious respiratory pathogens like Chlamydia pneumoniae, Mycoplasma pneumoniae
and Legionella spp. can cause severe atypical pneumonia. They do not respond to penicillin derivatives, which
may cause failure of antibiotic empirical therapy. The same applies for infections with B. pertussis and B.
parapertussis, the cause of pertussis disease, that may present atypically and need to be treated with macrolides.
Moreover, these fastidious bacteria are diﬃcult to identify by culture or serology, and therefore often remain
undetected. Thus, rapid and accurate identiﬁcation of bacterial pathogens causing atypical pneumonia is crucial.
We performed a retrospective method evaluation study to evaluate the diagnostic performance of the new,
commercially available Lightmix® multiplex RT-PCR assay that detects these fastidious bacterial pathogens
causing atypical pneumonia. In this retrospective study, 368 clinical respiratory specimens, obtained from pa-
tients suﬀering from atypical pneumonia that have been tested negative for the presence of common agents of
pneumonia by culture and viral PCR, were investigated. These clinical specimens have been previously char-
acterized by singleplex RT-PCR assays in our diagnostic laboratory and were used to evaluate the diagnostic
performance of the respiratory multiplex Lightmix® RT-PCR. The multiplex RT-PCR displayed a limit of detection
between 5 and 10 DNA copies for diﬀerent in-panel organisms and showed identical performance characteristics
with respect to speciﬁcity and sensitivity as in-house singleplex RT-PCRs for pathogen detection. The Lightmix®
multiplex RT-PCR assay represents a low-cost, time-saving and accurate diagnostic tool with high throughput
potential. The time-to-result using an automated DNA extraction device for respiratory specimens followed by
multiplex RT-PCR detection was below 4 h, which is expected to signiﬁcantly improve diagnostics for atypical
pneumonia-associated bacterial pathogens.
1. Introduction
Community-acquired pneumonia (CAP) is a severe infectious dis-
ease. The most common causative agents include viruses (like inﬂu-
enza) and bacterial pathogens (like Streptococcus pneumoniae and
Haemophilus inﬂuenzae) (WHO, 2016). Besides these “common” causes
of CAP, also fastidious bacterial pathogens (like Chlamydia pneumoniae,
Mycoplasma pneumoniae, Legionella pneumophila and Coxiella burnetii)
can cause so-called atypical pneumonia that accounts for up to 15% of
all CAP cases (Cunha, 2006). Reliable detection of agents of atypical
pneumonia is crucial as they do not respond to beta-lactams (Sharma
et al., 2016; Lamoth and Greub, 2010). Therefore, empiric treatment
with penicillin derivatives will be ineﬀective for their eradication if no
additional antibiotics (e.g. macrolides) are administered to the patient
(Bennett et al., 2014). Still, the detection of atypical bacterial agents of
CAP by culture or serology remains a challenge. Especially for C.
pneumoniae detection, serology shows low sensitivity and insuﬃcient
speciﬁcity, making this test clinically useless (Wellinghausen et al.,
2006). Rapid and accurate molecular methods are required for fast
identiﬁcation of bacterial pathogens causing atypical pneumonia and to
subsequently adapt the antibiotic regimen of the patients.
In this study, we present the ﬁrst evaluation of the multiplex
Lightmix® RT-PCR for simultaneous detection of the most important
bacterial pathogens causing atypical pneumonia, namely Bordetella
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parapertussis, Bordetella pertussis, Chlamydia pneumoniae,1 Chlamydia
psittaci, Legionella spp., Legionella pneumophila and Mycoplasma pneu-
moniae in clinical respiratory specimens.
Among the bacterial pathogens, the majority of CAP in children and
young adults is caused by M. pneumoniae resulting in mild to life-
threatening infections (Lieberman et al., 1996). For speciﬁc multiplex
RT-PCR detection, the repetitive element repMp1 was chosen as target.
Compared to single-copy targets, like the P1 adhesin gene, repMp1
enables more sensitive detection ofM. pneumoniae (Dumke et al., 2007).
L. pneumophila is an opportunistic bacterial pathogen that causes
severe pneumonia, especially in elderly and immunocompromised pa-
tients (Yu, 2000). The multiplex RT-PCR targets the 16S rRNA gene and
allows unambiguous diﬀerentiation of L. pneumophila from other Le-
gionella spp. by melting curve analysis.
B. pertussis and a speciﬁc lineage of B. parapertussis infect humans,
resulting in the typical symptoms of paroxysmal cough and whooping.
Many countries recently reported an increase of pertussis cases, espe-
cially in infants and adolescents that are unimmunized or incompletely
immunized with the pertussis vaccine (Heininger et al., 2014). More-
over, mixed outbreaks and co-infections with B. parapertussis and B.
pertussis have been reported (Zouari et al., 2012). To maximize sensi-
tivity, the multiplex RT-PCR targets the insertion sequences IS481
(50–100 copies per cell) and IS1001 (35–50 copies per cell) for speciﬁc
detection of B. pertussis and B. parapertussis, respectively.
C. pneumoniae is an obligate intracellular pathogen that accounts for
up to 10% of CAP cases and can be responsible for long-lasting disease
(Kuo et al., 1995). Although less common in recent series, C. pneumo-
niae still regularly causes small outbreaks (Asner et al., 2014). Note-
worthy, C. pneumoniae infection may sometimes mimic inaugural
asthma (Asner et al., 2014; Webley and Hahn, 2017) and thus may
remain undetected, since not tested. The multiplex RT-PCR targets the
single-copy gene ompA that encodes the C. pneumoniae major outer
membrane protein (MOMP) (Kuo et al., 1995).
Atypical pneumonia may also be caused by zoonotic transmission of
respiratory pathogens (e.g. Schack et al., 2014). C. psittaci is mostly
transmitted by domestic birds and causes psittacosis in humans leading
to potentially life-threatening disease (Smith et al., 2011). In addition,
poultry, wild bird species and even horses have also been reported to
transmit C. psittaci to humans, leading to single cases of infections or
even outbreaks (Smith et al., 2011; Rehn et al., 2013; Huijskens et al.,
2016). Thus, in order to prevent underdiagnosis, the analysis of re-
spiratory samples from patients with atypical pneumonia should in-
clude detection of C. psittaci. The multiplex RT-PCR targets the rpoB
gene encoding the β-subunit of RNA polymerase that provides high
taxonomic resolution and thus facilitates unambiguous C. psittaci de-
tection (Adékambi et al., 2009).
In this study, the diagnostic performance of the new multiplex
Lightmix® RT-PCR assay was evaluated for the detection of bacterial
pathogens causing atypical pneumonia.
2. Materials and methods
2.1. Clinical specimens, DNA extraction and singleplex RT-PCR assays used
in routine diagnostics
Respiratory clinical specimens (including sputum, bronchoalveolar
lavage, respiratory swabs, tracheal and nasopharyngeal secretions) from
patients with symptoms of atypical pneumonia were sent to our diag-
nostic laboratory for analysis (N=355). These clinical specimens have
been previously analysed by culture and viral PCR on the presence of
typical agents of CAP (data not shown) and were found to be negative.
We received extracted DNA from respiratory specimens (N=13) that
were tested positive for C. psittaci and C. pneumoniae, respectively from
the University Hospital of Lausanne, Switzerland.
One ml of the respiratory sample was centrifuged (10min, 14,000
rpm) and the supernatant was removed. Subsequently, 195 μl digest
buﬀer and 5 μl proteinase K were added to the pellet and incubated on a
thermomixer (2 h, 56 °C, 1000 rpm). DNA from clinical specimens was
extracted on the EZ1 Advanced XL (QIAGEN, Hombrechtikon,
Switzerland) using the EZ1 DNA Tissue Kit (QIAGEN, Hombrechtikon,
Switzerland), following the manufacturer’s instructions. Respiratory
pathogens were detected by singleplex in-house RT-PCR assays (SI
Methods, Table S1). DNA from the samples was stored at −20 °C for
further analysis.
2.2. Respiratory multiplex Lightmix® RT-PCR assay and melting curve
analysis
We used DNA from respiratory specimens (N=368) that has been
previously tested positive for at least one in-panel organism by single-
plex RT-PCR and retrospectively analysed it by multiplex Lightmix® RT-
PCR. All Lightmix® primers and probes (TIBMolbiol, Berlin Germany)
used in this study are commercially available and are currently labelled
“for research use only”. For multiplex RT-PCR, extracted DNA was
added to a mixture consisting of PCR grade water (Roche, Rotkreuz,
Switzerland), a LightCycler® DNA multiplex master mix (Roche) and the
Lightmix® primers and probes (TIBMolbiol). RT-PCR mastermix com-
position and the LightCycler® (LC) ampliﬁcation protocol were in ac-
cordance with the guidelines provided by TIBMolbiol. The RT-PCR was
performed using a LightCycler480-II® (for more information see SI
Methods).
2.3. Analytical performance of the respiratory multiplex Lightmix® RT-PCR
Bronchoalveolar lavage (BAL) specimens that were tested negative
in the singleplex RT-PCR assays were pooled and extracted on the EZ1
Advanced XL (QIAGEN), according to the manufacturer’s instructions
using the EZ1 DNA Tissue Kit (QIAGEN). Analytical sensitivity for each
bacterial pathogen was determined by serial dilution of the respective
positive control plasmid (5–1000 DNA copies per RT-PCR reaction; Fig.
S1) in the BAL extracts. This allowed the generation of a standard curve
and the quantiﬁcation of positive samples (Fig. S1). The intra-run re-
producibility was assessed in duplicates using the respective positive
control plasmid diluted in the BAL extracts (5–1000 DNA copies per RT-
PCR reaction; Fig. S2 and Table S2). To determine the inter-assay
variability, 6 clinical respiratory samples were analysed by 3 diﬀerent
technicians on 3 consecutive days (Table S3).
2.4. Performance characteristics of the respiratory multiplex RT-PCR in
comparison to in-house RT-PCRs
To assess the performance of the multiplex RT-PCR, bacterial strains
that are commonly found in respiratory samples or that are part of the
human microbial ﬂora and reference strains of 8 Legionella spp. were
analysed, respectively (Table 2 and Table S4). The 8 Legionella spp.
were chosen based on 16S rDNA diversity and expert opinion. Fur-
thermore, we investigated the performance of the multiplex RT-PCR
with clinical respiratory specimens that have been previously char-
acterized by singleplex in-house RT-PCR assays (N= 368) (Fig. 1 and
Table 1).
2.5. Statistical methods
To determine diﬀerences in diagnostic performance of the single-
plex and multiplex RT-PCR, Ƙ-statistics (Cohen, 1960) and the Bland
and Altmann plot (Bland and Altman, 1995) were used. The inter-assay
1 In this study, the genus name Chlamydia and not Chlamydophila is used throughout for
C. pneumoniae and C. psittaci according to the most recent taxonomic classiﬁcation and
expert opinion (Gilbert Greub; Bavoil P, Kaltenboeck B, Greub G. In Chlamydia veritas.
Pathog Dis 2013;67:89-90. doi: 10.1111/2049-632X.12026).
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and intra-assay variability (i.e. variation coeﬃcients) were calculated
by dividing the standard deviation of the cycling threshold (Ct) values
from the replicates in the multiplex RT-PCR by the mean of the Ct
values from the replicates. All data analysis and data visualization was
done in R (Team R, 2011).
Fig. 1. Detection of respiratory pathogens by multiplex Lightmix® RT-PCR in clinical specimens (N=368) and the corresponding cycling threshold (Ct) values.
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2.6. Ethics
The study was conducted according to good laboratory practice and
in accordance with the Declaration of Helsinki and national and in-
stitutional standards.
3. Results
3.1. Analytical performance of the multiplex Lightmix® RT-PCR
The analytical sensitivity of the multiplex RT-PCR was evaluated
using serial dilutions (5–1000 DNA copies per RT-PCR reaction) of the
positive control plasmids in negative BAL specimens. For all respiratory
pathogens analysed, the limit of detection (LOD) was determined to be
between 5 and 10 DNA copies per RT-PCR reaction (Fig. S1). The intra-
run variability was assessed by plotting the Ct values of sample re-
plicates analysed in the same RT-PCR run. The R2 was excellent for each
respiratory pathogen (i.e. R2≥ 0.95) (Fig. S2), and the variation coef-
ﬁcient of the intra-run variability was<3% (Table S2). The inter-run
variability was< 5% indicating high reproducibility of the multiplex
RT-PCR results independent of the analyst performing the assay (Table
S3).
3.2. Performance characteristics of the respiratory multiplex RT-PCR in
comparison to in-house RT-PCRs
In total, 368 clinical respiratory specimens were analysed by mul-
tiplex RT-PCR. Seven samples tested positive for B. parapertussis, 170
for B. pertussis, 3 for C. pneumoniae, 11 for C. psittaci, 20 for L. pneu-
mophila, 11 for Legionella spp. and 146 for M. pneumoniae, respectively
(Table 1 and Fig. 1). Moreover, in two patients a co-infection of B.
pertussis and B. parapertussis was observed (Fig. S3). This underlines the
good diagnostic performance of the multiplex RT-PCR, also for clinical
samples with more than one bacterial pathogen present (Fig. S3). In all
368 clinical specimens, the multiplex RT-PCR detected the same pa-
thogen as the corresponding singleplex RT-PCR that is used in our ISO
accredited diagnostic laboratory. Ƙ-statistics (Cohen, 1960) showed
perfect agreement between the singleplex and the multiplex RT-PCR for
the detection of all respiratory pathogens (Table 1). The Bland and
Altman plot (Bland and Altman, 1995) showed that Ct values of the
singleplex and the multiplex RT-PCR were evenly scattered above and
below zero, revealing no bias of one approach versus the other (Fig. 2).
In both, the singleplex and the multiplex RT-PCR, 5 Ct values were
outside the 1.96 SD of the mean (Fig. 2).
To determine the speciﬁcity of the multiplex RT-PCR, diﬀerent
bacterial isolates were analysed that all tested negative, except B. hol-
mesii that showed a positive ampliﬁcation signal with the B. pertussis
Lightmix® primer/probe set (Table 2). This is based on the fact that the
IS481 insertion sequence is also present in some B. holmesii isolates
(Pittet et al., 2014).
3.3. Discrimination of L. pneumophila from other Legionella spp.
All Legionella spp. analysed showed a positive ampliﬁcation signal in
the multiplex RT-PCR and could thereby be clearly identiﬁed as posi-
tive. In melting curve analysis, all L. pneumophila serogroups showed a
peak at 62 °C and enabled their unambiguous diﬀerentiation from other
Legionella spp. (Fig. 3 and Table S4). Diﬀerent Legionella spp. displayed
either no peak or a peak between 48 °C and 55 °C (Table S4), respec-
tively.
4. Discussion
We investigated the diagnostic performance of a commercial mul-
tiplex RT-PCR that targets therapeutically relevant bacterial agents of
atypical pneumonia. In general, accuracy and reproducibility of the
multiplex RT-PCR results were very good. Moreover, analytical sensi-
tivity and speciﬁcity of the multiplex RT-PCR was equal to the single-
plex in-house RT-PCRs that are used in our accredited diagnostics la-
boratory. Despite excellent speciﬁcity of the multiplex RT-PCR, we
obtained one false-positive result with a sample containing B. holmesii.
This owes to the fact that most PCR assays used in routine diagnostics
Table 1
Detection of atypical respiratory pathogens in clinical specimens by multiplex Lightmix®
RT-PCR and agreement of singleplex RT-PCR vs. multiplex RT-PCR results (ƙ statistics).
B. parapertussis Singleplex RT-PCR
Negative Positive
Multiplex Lightmix®
RT-PCR
Negative 361 0 Ƙ=1
Positive 0 7
B. pertussis Singleplex RT-PCR
Multiplex Lightmix®
RT-PCR
Negative Positive
Negative 198 0 Ƙ=1
Positive 0 170
C. pneumoniae Singleplex RT-PCR
Multiplex Lightmix®
RT-PCR
Negative Positive
Negative 365 0 Ƙ=1
Positive 0 3
C. psittaci Singleplex RT-PCR
Multiplex Lightmix®
RT-PCR
Negative Positive
Negative 357 0 Ƙ=1
Positive 0 11
L. pneumophila Singleplex RT-PCR
Multiplex Lightmix®
RT-PCR
Negative Positive
Negative 348 0 Ƙ=1
Positive 0 20
Legionella spp. Singleplex RT-PCR
Multiplex Lightmix®
RT-PCR
Negative Positive
Negative 357 0 Ƙ=1
Positive 0 11
M. pneumoniae Singleplex RT-PCR
Multiplex Lightmix®
RT-PCR
Negative Positive
Negative 222 0 Ƙ=1
Positive 0 146
Table 2
Bacterial strains used for determining the speciﬁcity of the multiplex Lightmix
®
RT-PCR.
Species RT-PCR Result
Corynebacterium spp. C. amycolatum −
C. propinquum −
C. imitans −
C. pseudodiphtheriticum −
Escherichia spp. E. coli −
Staphylococcus spp. S. aureus −
S. caprae −
S. epidermidis −
S. gallinarum −
S. haemolyticus −
S. hominis −
S. lugdunensis −
S. pettenkoferi −
S. warneri −
Streptococcus spp. S. anginosus −
S. constellatus −
S. bovis −
S. gallolyticus −
S. gordonii −
S. intermedius −
S. mitis −
S. mutans −
S. oralis −
S. salivarius −
Bordetella spp. B. holmesii +
B. bronchiseptica −
Chlamydia spp. C. trachomatis −
C. abortus –
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for B. pertussis detection target the insertion sequence IS481 (Dalby
et al., 2013), which is also present in some B. holmesii isolates. To cir-
cumvent this problem, respiratory specimens with a positive B. pertussis
ampliﬁcation signal in the multiplex RT-PCR could be subjected to a
second RT-PCR assay that targets genes exclusively found in B. pertussis,
like the pertussis toxin gene (Sloan et al., 2002). However, since these
genes, unlike IS481, are single-copy targets, RT-PCR is less sensitive,
and therefore may lead to false-negative results (Sloan et al., 2002). The
16S rRNA gene is also not an appropriate discriminator since B. holmesii
shares more than 99% sequence similarity in the 16S rRNA sequence
with B. pertussis (Gross et al., 2010). In summary, we consider the
utilization of IS481as an appropriate target for the detection of B. per-
tussis as its high sensitivity outweighs the limitations in speciﬁcity.
The multiplex RT-PCR allowed a very accurate diﬀerentiation be-
tween L. pneumophila and other, potentially apathogenic Legionella spp.
Most cases of Legionnaires’ disease reported are associated with L.
pneumophila, especially serotype 1 (Fields et al., 2002). This may reﬂect
a diagnosis bias, because most commercially available kits exclusively
detect L. pneumophila serotype 1 antigen in urine specimens. The
Lightmix® multiplex RT-PCR allowed identiﬁcation of diﬀerent L.
pneumophila serotypes and Legionella spp. Some Legionella spp. showed
no Tm peak in melting curve analysis. This may be explained by the fact
that some Legionella spp. show basepair mismatches with the Lightmix®
genus probe used in the assay. This does not pose a problem for the
analysis, as L. pneumophila can readily be discriminated from other
Legionella spp. by showing a peak at 62 °C. If identiﬁcation of Legionella
spp. other than L. pneumophila is required, 16S rDNA sequencing may
be used for species identiﬁcation. However, when 16S rDNA sequencing
from specimens with Ct values higher 30 in the multiplex RT-PCR was
performed, interpretation of the Sanger electropherograms was often
not possible (i.e. weak peaks or multiple overlaying peaks in the elec-
tropherograms).
Various multiplex panels for simultaneous detection of diverse pa-
thogens causing pneumonia have been developed like the Unyvero® P55
(Curetis AG, Holzgerlingen, Germany), NxTAG® Respiratory Pathogen
Panel (Luminex, Hertogenbosch, The Netherlands), RespiFinder® 22
(PathoFinder, Maastricht, The Netherlands) or Seeplex® PneumoBacter
ACE Detection (Seegene Inc., Seoul, South Korea) (e.g. Babady, 2013;
Beckmann and Hirsch, 2016; Ozongwu et al., 2017). However, these are
mostly syndromic assays and costly, often needing test-speciﬁc equip-
ment and consumables that are not aimed for high-throughput
screening in molecular diagnostic laboratories. In addition, such test
panels often include viral agents without speciﬁc therapeutic con-
sequences. Moreover, the application of highly multiplexed assays as
ﬁrst-line tests in diagnostics of CAP is subject of controversial discus-
sion (Schreckenberger and McAdam, 2015) since the mere presence of
Fig. 2. Bland Altman Plot comparing the cycling threshold (Ct) values
from the singleplex and multiplex RT-PCRs.
Fig. 3. L. pneumophila (red) showed a distinct melting temperature of 62 °C, whereas
Legionella spp. (black) showed either no melting curve or a melting temperature lower
55 °C in melting curve analysis. (For interpretation of the references to colour in this
ﬁgure legend, the reader is referred to the web version of this article.)
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an organism does not necessarily indicate its contribution to disease.
Many bacterial and viral agents with pathogenic potential in the lung
may also be present in the upper respiratory tract of healthy individuals
in a carriage state or may be detected after resolution of infection due to
prolonged shedding (e.g. Skevaki et al., 2015; Kumar et al., 2008).
Therefore, asymptomatic carriage of viruses and bacterial pathogens
(e.g. S. pneumoniae) in the upper respiratory tract poses a diagnostic
problem. In contrast, no carriage of bacterial pathogens causing aty-
pical pneumonia was found in respiratory secretions (Kumar et al.,
2008), indicating that positive test results correlate with clinical dis-
ease. However, there are also contradictory reports stating that M.
pneumoniae may be carried asymptomatically in the upper respiratory
tract of children (Sauteur et al., 2016). Therefore, it is crucial to adhere
to clinical case deﬁnitions and follow clinical decision rules as RT-PCR
testing is unable to diﬀerentiate M. pneumoniae carriage from infection
(Sauteur et al., 2016).
Our study has several limitations: It was designed as single centre
laboratory-based, retrospective method evaluation study with pre-
selected clinical specimens. The total number of samples tested positive
for individual in-panel organisms like C. psittaci and C. pneumoniae is
low at our institute (one positive C. pneumoniae detection in the past 5
years). In order to correct for low positive sample counts for C. psittaci
and C. pneumoniae, additional samples that were tested positive at an-
other University Hospital (CHUV, Lausanne, Switzerland) were added
to the sample set. Since our study does not reﬂect a true epidemiology
and since positive predictive values of molecular assays depend on the
prevalence of in-panel organisms, clinical specimens with a positive test
result for Chlamydia spp. should be conﬁrmed by an alternative assay or
send to a reference laboratory for conﬁrmatory testing.
5. Conclusion
In conclusion, the multiplex Lightmix® RT-PCR provides a reliable
tool to overcome underdiagnosis of atypical pneumonia, allowing im-
proved, targeted therapy and application of appropriate infection con-
trol measures. The multiplex Lightmix® RT-PCR showed a good diag-
nostic performance that is comparable to singleplex in-house RT-PCR
assays with respect to speciﬁcity and sensitivity. Moreover, the multi-
plex Lightmix® RT-PCR enabled accurate detection of B. pertussis and B.
parapertussis in co-infected patients. We propose a diagnostic workﬂow
with low per sample costs using an automated DNA extraction device
(e.g. QIASymphony) and multiplex Lightmix® RT-PCR detection. Up to
24 samples can be analysed in parallel in this workﬂow within less than
4 h. Therefore, it is suitable for high-throughput routine screening of
multiple important respiratory pathogens causing atypical pneumonia.
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